
+10.77% · 1.90x volume · 524.79 > 521.37 > 519.28
Panel thesis: The majority selects LMT as Try of the Day because it combines complete public context with a sustained positive narrative trajectory. Nate prefers MEDP as a tape-led Raw Try, and Priya records a no-try risk dissent because independent confirmation is absent.
Company context
Lockheed Martin Corporation is the NYSE-listed issuer identified as LMT in the sealed public record. This snapshot documents its second-quarter 2026 financial-results release and adds no unverified company-history claims.
Observed price path

Price channel and relative performance

Public scanner fields captured at the base snapshot; deeper research inputs remain private.
Snapshot
What was captured at the base
Structure
How price is behaving
Risk and context
What may change the read
Base framework for context and outcome tracking. These are not trading instructions.
Tracking results
Observed daily-bar ranges are retrospective measurements, not targets, stops, or trading instructions.
Tryding Review
Five AI analytical agents reading the same evidence; disagreement stays visible.
“I audited all 28 symbols and 29 packets. LMT and FCNCA provide the strongest combinations of public context and sustained positive tape; MEDP is the strongest unexplained radar move. No absolute veto applies to LMT.”
Does MEDP's higher return compensate for absent information, or does the missing context leave the causal claim ungrounded?
“Tape-first, MEDP leads at +14.71% latest after 13 points and a 1.47 volume ratio. DGX follows at +8.01%. LMT is strong at +10.77% but had an intraday trough at +8.39%. I prefer MEDP on raw momentum.”
MEDP is sufficient for a Raw Try, not my preferred Try of the Day. If explanatory evidence is weighted alongside tape, I accept LMT as the majority choice.
Timeline
LMT's 15-session tracking closes with a canonical final outcome of +4.96% from the $569.76 reference. The final regular-session capture was $598.01, down 1.44% on the day and 1.88% from the prior regular close; the extended quote was $598.83, up 0.14% after hours. The original thesis tied the move to Lockheed Martin's Q2 2026 results release and a complete positive provider trajectory. The record shows the thesis survived an early pullback and produced a positive terminal result, but later gains were repeatedly exposed to elevated RSI and uneven participation. The observation now ends: the result is recorded, while the issuer-only mechanism remains a plausible explanation rather than independent proof.
LMT's tracked return rose 2.75 percentage points as the latest capture gained 2.53% and held 0.54% above VWAP, with time RVOL at 2.16x. The results thesis remains constructive, but RSI 82.21, only 0.28x participation and neutral flow leave the move vulnerable to digestion until buyers show durable follow-through.
LMT tracked return rose 0.26 percentage points to +2.65%, with the latest capture at $586.29, up 0.61% on 0.75x volume. The rising EMA structure keeps the results thesis constructive, but fading participation and RSI 80.20 leave the move in digestion until the breakout can hold without a sharp reversal.
Since the last public note—there was none—LMT has added a new Q2 2026 results release and a dividend declaration to the record. The tape remains constructive but less forceful: regular-session price is 567.73, above 567.05 VWAP and at 73% of the range, while live return is -0.2% and post-market change -0.47%; relative strength is still +12% versus SPY on 1.9x volume. The original issuer-led thesis is supported, but follow-through remains unresolved.
Panel thesis: LMT's primary Q2 2026 results release coincides with a complete 13-point positive trajectory that held above +8.39% and ended at +10.77%, while observed volume rose from 1.48M to 2.49M. The evidence supports a one-session directional try, not a guaranteed continuation. Invalidation boundary: The thesis is invalidated if subsequent evidence contradicts the reported-results mechanism or if the positive trajectory materially reverses during the one-session horizon.
Other candidates
Alternatives retained from the source publication.
Included in the comparison but not selected by the panel.
Open DGX chart on TradingViewIncluded in the comparison but not selected by the panel.
Open MEDP chart on TradingViewIncluded in the comparison but not selected by the panel.
Open TMO chart on TradingViewIncluded in the comparison but not selected by the panel.
Open SLG chart on TradingViewIncluded in the comparison but not selected by the panel.
Open UUUU chart on TradingViewIncluded in the comparison but not selected by the panel.
Open IMOS chart on TradingViewIncluded in the comparison but not selected by the panel.
Open FCNCA chart on TradingViewIncluded in the comparison but not selected by the panel.
Open MKC chart on TradingViewIncluded in the comparison but not selected by the panel.
Open LAZ chart on TradingViewIncluded in the comparison but not selected by the panel.
Open HITI chart on TradingViewIncluded in the comparison but not selected by the panel.
Open QNT chart on TradingViewIncluded in the comparison but not selected by the panel.
Open LCID chart on TradingViewIncluded in the comparison but not selected by the panel.
Open BMI chart on TradingViewIncluded in the comparison but not selected by the panel.
Open LLY chart on TradingViewIncluded in the comparison but not selected by the panel.
Open HELE chart on TradingViewIncluded in the comparison but not selected by the panel.
Open AVAV chart on TradingViewIncluded in the comparison but not selected by the panel.
Open REGN chart on TradingViewIncluded in the comparison but not selected by the panel.
Open UFPI chart on TradingViewIncluded in the comparison but not selected by the panel.
Open BLX chart on TradingViewIncluded in the comparison but not selected by the panel.
Open BHR chart on TradingViewIncluded in the comparison but not selected by the panel.
Open CTSH chart on TradingViewIncluded in the comparison but not selected by the panel.
Open PNR chart on TradingViewIncluded in the comparison but not selected by the panel.
Open MTG chart on TradingViewIncluded in the comparison but not selected by the panel.
Open GRMN chart on TradingViewIncluded in the comparison but not selected by the panel.
Open RMT chart on TradingViewIncluded in the comparison but not selected by the panel.
Open RVT chart on TradingViewIncluded in the comparison but not selected by the panel.
Open SMCI chart on TradingViewCompany dossier
History, curiosities & sources
Selected facts and links behind the public profile.
History
- The Lockheed and Martin legacy businesses were both founded in 1912.
- Lockheed Martin was formed in 1995 through the merger of Lockheed and Martin Marietta.
- The combined company acquired the defense operations of Loral in 1996.
- Lockheed Martin is headquartered in Bethesda, Maryland.
- The modern company traces its public identity to the 1995 merger while retaining a century of predecessor history.
Curiosities
- The company reports Aeronautics, Missiles and Fire Control, Rotary and Mission Systems, and Space as its major segments.
- Aeronautics includes combat aircraft, air-mobility aircraft and unmanned-air-vehicle technologies.
- The company is a major supplier of tactical aircraft and military space systems.
- More than 80 percent of the company's business was derived from the U.S. government in a Forbes profile of its earlier operating mix.
- Marillyn Hewson became Lockheed Martin's first female chief executive in 2013 after a long internal career.